- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2055-7124
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Nonviral delivery systems for antisense oligonucleotide therapeutics ; volume:26 ; number:1 ; day:30 ; month:9 ; year:2022 ; pages:1-23 ; date:12.2022
Biomaterials Research ; 26, Heft 1 (30.9.2022), 1-23, 12.2022
- Urheber
-
Huang, Si
Hao, Xin-Yan
Li, Yong-Jiang
Wu, Jun‑Yong
Xiang, Da-Xiong
Luo, Shilin
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40824-022-00292-4
- URN
-
urn:nbn:de:101:1-2022121809062485671859
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Huang, Si
- Hao, Xin-Yan
- Li, Yong-Jiang
- Wu, Jun‑Yong
- Xiang, Da-Xiong
- Luo, Shilin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Delivery of oligonucleotide‐based therapeutics: challenges and opportunities
Triazine-cored polymeric vectors for antisense oligonucleotide delivery in vitro and in vivo
Antisense oligonucleotide therapeutic approach for Timothy syndrome
Systemic Brain Delivery of Oligonucleotide Therapeutics Enhanced by Protein Corona‐Assisted DNA Cubes
Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
Oligonucleotide therapeutics in sports? An antidoping perspective
Pharmacological studies of antisense oligonucleotide microRNA inhibitors
Profiled support vector machines for antisense oligonucleotide efficacy prediction
Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
Multi-targeted Antisense Oligonucleotide Delivery by a Framework Nucleic Acid for Inhibiting Biofilm Formation and Virulence
Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
Emerging non-viral vectors for gene delivery
Delivery of oligonucleotide‐based therapeutics: challenges and opportunities
Triazine-cored polymeric vectors for antisense oligonucleotide delivery in vitro and in vivo
Antisense oligonucleotide therapeutic approach for Timothy syndrome
Systemic Brain Delivery of Oligonucleotide Therapeutics Enhanced by Protein Corona‐Assisted DNA Cubes
Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
Oligonucleotide therapeutics in sports? An antidoping perspective
Pharmacological studies of antisense oligonucleotide microRNA inhibitors
Profiled support vector machines for antisense oligonucleotide efficacy prediction
Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
Multi-targeted Antisense Oligonucleotide Delivery by a Framework Nucleic Acid for Inhibiting Biofilm Formation and Virulence
Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
Emerging non-viral vectors for gene delivery
Delivery of oligonucleotide‐based therapeutics: challenges and opportunities
Triazine-cored polymeric vectors for antisense oligonucleotide delivery in vitro and in vivo
Antisense oligonucleotide therapeutic approach for Timothy syndrome
Systemic Brain Delivery of Oligonucleotide Therapeutics Enhanced by Protein Corona‐Assisted DNA Cubes
Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
Oligonucleotide therapeutics in sports? An antidoping perspective
Pharmacological studies of antisense oligonucleotide microRNA inhibitors
Profiled support vector machines for antisense oligonucleotide efficacy prediction
Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
Multi-targeted Antisense Oligonucleotide Delivery by a Framework Nucleic Acid for Inhibiting Biofilm Formation and Virulence
Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle